Biotechnology opens up new avenues for detecting relapses and developing treatments for lu... 17/11/2026 Lung cancer remains one of the major public health challenges. In 2024, 2.6 million new cases and 1.9 million deaths... AseBio
Lung cancer: from early detection of recurrence to new therapies, biotechnology takes on o... 17/11/2026 Healthcare In vitro diagnostics Personalized medicine On the occasion of International Lung Cancer Awareness Day, we highlight the advances made by Flomics Biotech and Oryzon... AseBio
Montserrat Bernabeu Guitart: “innovation and knowledge transfer play a strategic role at ... 05/11/2026 Healthcare Access to innovation Personalized medicine Montserrat Bernabeu Guitart is a specialist in Physical Medicine and Rehabilitation, and Co-director and Director of... Partners - GENESIS Biomed
Madrid Science Park strengthens the Spanish biotech ecosystem as an official provider of S... 05/11/2026 Healthcare Personalized medicine Digitalization The validation of this disruptive technology, born from a strategic alliance with the CNB-CSIC and the BGI Group... Partners
VIVA In Vitro Diagnostics and ASKA Biotech announce strategic partnership to advance VIVA-... 04/11/2026 Healthcare In vitro diagnostics Personalized medicine The Spanish biotechnology company and German CDMO join forces to advance the development and manufacturing of VIVA-ELISA... Partners - VIVA IN VITRO
From electronic health records to real-world evidence: Savana Next-Generation Registry dig... Savana, Calle Larra 12, Madrid. Spain Del 23/10/2026 18:30 to 23/10/2026 Healthcare Personalized medicine Digitalization
Biomarkers and artificial intelligence open new avenues for anticipating Alzheimer’s progr... 21/09/2026 Healthcare Drug discovery Personalized medicine In Spain, nearly one million people were living with dementia in 2025, according to estimates from Alzheimer Europe... Partners - ADmit Therapeutics
Biomarkers and artificial intelligence open new avenues for anticipating Alzheimer’s progr... 21/09/2026 ADmit Therapeutics In Spain, nearly one million people were living with dementia in 2025, according to estimates from Alzheimer Europe... AseBio - ADmit Therapeutics
Biotechnology is driving earlier and more personalised approaches to sepsis 13/09/2026 Healthcare In vitro diagnostics Personalized medicine Together with clinical experts, researchers and our partner Viva In Vitro Diagnostics, we analyse the main challenges in... AseBio - VIVA IN VITRO
Sepsis causes 11 million deaths every year, while new biomarkers are paving the way for a ... 13/09/2026 VIVA IN VITRO In Spain, around 50,000 people are affected by sepsis each year and approximately 17,000 die, highlighting the... AseBio - VIVA IN VITRO